Treatment of rheumatologic diseases with interleukin inhibitors may raise patients’ risks for serious and opportunistic infections and possibly also cancer, researchers reported in JAMA Network Open in October.
https://www.rheumatologynetwork.com/news/interleukin-inhibitors-may-raise-infection-cancer-risks